Publication:
Investigation of TEM-1 and SHV-1 Beta-Lactamase ligand binding

dc.contributor.authorsKanlikiliçer P., Ölmez E.Ö., Büdeyri N., Akbulut B.S.
dc.date.accessioned2022-03-15T01:57:52Z
dc.date.accessioned2026-01-11T13:53:53Z
dc.date.available2022-03-15T01:57:52Z
dc.date.issued2010
dc.description.abstractThe abuse, overuse and misuse of beta-lactam antibiotics in treating bacterial infections have caused bacteria to develop resistance against them. One common antibiotic resistance mechanism utilized by bacteria is the production of beta-lactamase enzymes that cleave the amide bond in betalactam ring rendering the antibiotic ineffective. One way to combat this problem is to use beta-lactamase inhibitors in combination with beta-lactam antibiotics. Beta-lactamase inhibitor protein (BLIP) is an effective inhibitor of class A betalactamases such as TEM-1 and SHV-1. In the current research, the binding of BLIP to TEM-1 and to SHV-1 beta lactamase was investigated using molecular dynamics simulations. The binding free energies of BLIP complex with TEM-1 and SHV-1 betalactamases were calculated using Molecular Mechanic Poisson Bolztmann Surface Area (MM-PBSA) methodology. It was found that BLIP has significant differences in binding affinities toward TEM-1 and SHV-1 beta-lactamases. ©2009 IEEE.
dc.identifier.doi10.1109/HIBIT.2010.5478885
dc.identifier.isbn9781424459704
dc.identifier.urihttps://hdl.handle.net/11424/247013
dc.language.isoeng
dc.relation.ispartof2010 5th International Symposium on Health Informatics and Bioinformatics, HIBIT 2010
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBinding free energy
dc.subjectBLIP
dc.subjectMolecular dynamics
dc.subjectSHV-1 beta-lactamase
dc.subjectTem-1 beta-lactamase
dc.titleInvestigation of TEM-1 and SHV-1 Beta-Lactamase ligand binding
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage172
oaire.citation.startPage167
oaire.citation.title2010 5th International Symposium on Health Informatics and Bioinformatics, HIBIT 2010

Files